Concepedia

Paul Nioi

PN

Statistics

Publications

34

Citations

4.6K

H-Index

25

Active since

2003

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Amgen (United States)

Pfizer (United States)

Bristol-Myers Squibb (United States)

Regeneron (United States)

Paul Nioi is an author at Alnylam Pharmaceuticals (United States) specializing in life sciences, genetics, and medicine.

ORCID

Publications per year

2003–2023

34

Publications

34

Plasma proteomic associations with genetics and health in the UK Biobank

Benjamin B. Sun, Joshua Chiou, Matthew Traylor et al. · Nature · 2023 · 1.5K citations · Full text

, , +16

Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence

Paul Nioi, Michael McMahon, Ken Itoh et al. · Biochemical Journal · 2003 · 497 citations · Full text

, , +15

The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation

Paul Nioi, Truyen Nguyen, Philip J. Sherratt et al. · Molecular and Cellular Biology · 2005 · 376 citations

, , +17

Nrf2 Controls Constitutive and Inducible Expression of ARE-driven Genes through a Dynamic Pathway Involving Nucleocytoplasmic Shuttling by Keap1

Truyen Nguyen, Philip J. Sherratt, Paul Nioi et al. · Journal of Biological Chemistry · 2005 · 341 citations · Full text

, , +17

A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity

Paul Nioi, Truyen Nguyen · Biochemical and Biophysical Research Communications · 2007 · 209 citations

, , +8

1–5 of 34